Announcements Trials
Browse Landscape

Status

Completed 7Not yet recruiting 5Terminated 4Recruiting 4Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Gastrointestinal 3Sarcoma 2Myeloid 2Lymphoid 2Gynecologic 2Tumor-Agnostic 1Thoracic 1Head & Neck 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 1Lung Neoplasms 1Disease 1Death 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Interviews as Topic × Thoracic × Clear all
NCT01389830 2019-07-18

End of Life Treatment Preferences of Latino Medicare Beneficiaries With Cancer

M.D. Anderson Cancer Center

Unknown
230 enrolled
BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Death, Disease, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡